U
UroGen Pharma Ltd.
URGN · NASDAQ · Healthcare · 2.3B
Price · close
$46.86
+0.13% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-16.8×
Free cash flow yieldFCF yield
-7.2%
Return on equityROE
145.5%
Operating margin
-113.7%
Net debt / EBITDAbalance-sheet strength
-0.1×
Interest coverage
-3.7×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.